Search results
Showing 5791 to 5805 of 7682 results
Recommendation ID DG36/2 Question secondary research is recommended to understand the clinical validity of enzyme-linked immunosorbent
Recommendation ID NG22/5 Question Self-management:- What is the impact of different early intervention-focused approaches to self-management
Recommendation ID DG36/3 Question Secondary research is recommended to understand the comparative performance of different ELISA tests
Recommendation ID NG82/5 Question Self-monitoring strategies:- Does earlier detection of the incidence of late AMD (wet active) by self-monitoring
Recommendation ID NG80/7 Question Second-line maintenance therapy in children and young people (under 16):- Is maintenance therapy more
Recommendation ID MTG51/1 Question SEM Scanner 200, with visual skin assessment, shows promise for preventing pressure ulcers. However
Recommendation ID NG20/1 Question Serological testing in people who have IgA deficiency:- What is the sensitivity and specificity of IgG
Recommendation ID NG20/2 Question Serological testing in people who test negative for anti-transglutaminase:- What is the sensitivity and
Recommendation ID NG22/2 Question Service delivery models:- Which models of service delivery are effective and cost-effective for older
Recommendation ID CG151/1 Question Service provision for neutropenic sepsis in patients with cancer:- A prospective national cohort study
Recommendation ID DG1/1 Question Research is needed to quantify the health outcome benefits associated with imaging improvements with the
Recommendation ID MTG21/1 Question Research is recommended to address uncertainties about the claimed patient and system benefits of the
Recommendation ID MTG4/1 Question Research is recommended in the UK clinical setting to compare the BRAHMS copeptin assay in combination
Recommendation ID MTG20/1 Question Research is recommended to address uncertainties about the claimed patient and system benefits of using
Recommendation ID MTG22/1 Question Research is recommended to address uncertainties in the potential benefits to patients and the NHS of